A role for BNP assays in monitoring aortic valve disease for optimal timing of surgery

International Journal of Cardiology

Volumn 127, Issue 3, 2008, Pages 328-330

  Shaw, S M ^a   Lewis, N T ^b   Williams, S G ^a   Tan, L B ^b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Aortic regurgitation; Aortic stenosis; Brain natriuretic peptide; Cardiac function; Echocardiography; Timing of surgery

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EDITORIAL; EXERCISE; HUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SURGICAL RISK; TRANSTHORACIC ECHOCARDIOGRAPHY;

BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; HEART VALVE DISEASES; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; TIME FACTORS;

EID: 46049083050     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.12.035     Document Type: Editorial

References (28)

1. Zoghbi W.A., Enriquez-Sarano M., Foster E., et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16 (2003) 777-802
2. Daniel W.G., Hood Jr. W.P., Siart A., et al. Chronic aortic regurgitation: reassessment of the prognostic value of preoperative left ventricular end-systolic dimension and fractional shortening. Circulation 71 (1985) 669-680
3. Taniguchi K., Nakano S., Hirose H., et al. Preoperative left ventricular function: minimal requirement for successful late results of valve replacement for aortic regurgitation. J Am Coll Cardiol 10 (1987) 510-518
4. Michel P.L., Iung B., Abou J.S., et al. The effect of left ventricular systolic function on long term survival in mitral and aortic regurgitation. J Heart Valve Dis 4 Suppl 2 (1995) S160-S168
5. Klodas E., Enriquez-Sarano M., Tajik A.J., et al. Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms. J Am Coll Cardiol 30 (1997) 746-752
6. Turina J., Milincic J., Seifert B., and Turina M. Valve replacement in chronic aortic regurgitation: true predictors of survival after extended follow-up. Circulation 98 (1998) II100-II106
7. Dujardin K.S., Enriquez-Sarano M., Schaff H.V., et al. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation 99 (1999) 1851-1857
8. Tornos P., Sambola A., Permanyer-Miralda G., et al. Long-term outcome of surgically treated aortic regurgitation: influence of guideline adherence toward early surgery. J Am Coll Cardiol 47 (2006) 1012-1017
9. ACC/AHA. 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). Circulation 11 (2006) e84-e231
10. Kinnunen P., Vuolteenaho O., and Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology 132 (1993) 1961-1970
11. Harrison A., Morrison L.K., Krishnaswamy P., et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 39 (2002) 131-138
12. Gardner R.S., Zalp Z., Murday A.J., Robb S.D., and McDonagh T.A. N-terminal pro-brain natriuretic peptide: a new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24 (2003) 1735-1743
13. Williams S.G., Ng L.L., O'Brien R.J., Taylor S., Wright D.J., and Tan L.B. Is plasma N-BNP a good indicator of the functional reserve of failing hearts? The FRESH-BNP study. Eur J Heart Fail 6 (2004) 891-900
14. Weber M., Hausen M., Arnold R., et al. Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation. Int J Cardiol 127 (2008) 321-327
15. Gerber I.L., Stewart R.A., French J.K., et al. Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation. Am J Cardiol 92 (2003) 755-758
16. Bonow R.O., Carabello B.A., Chatterjee K., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease). Circulation 114 (2006) e84-e231
17. Van Pelt N.C., Kerr A.J., Legget M.E., et al. Increased B-type natriuretic peptide is associated with an abnormal blood pressure response to exercise in asymptomatic aortic stenosis. Int J Cardiol 127 (2008) 313-320
18. Talwar S., Downie P.F., Squire I.B., Davies J.E., Barnett D.B., and Ng L.L. Plasma N-terminal proBNP and cardiotrophin-1 are elevated in aortic stenosis. Eur J Heart Fail 3 (2001) 15-19
19. Qi W., Mathisen P., Kjekshus J., et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J 142 (2001) 725-732
20. Gerber I.L., Stewart R.A., Legget M.E., et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 107 (2003) 1884-1890
21. Weber M., Arnold R., Rau M., et al. N-terminal pro braintype natriuretic peptide (NTproBNP) is a highly sensitive biochemical marker for surgical therapy in patients with aortic stenosis. Circulation 108 (2003) IV 513
22. Weber M., Arnold R., Rau M., et al. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol 94 (2004) 740-745
23. Bergler-Klein J., Klaar U., Heger M., et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 109 (2004) 2302-2308
24. Lim P., Monin J.L., Monchi M., et al. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J 25 (2004) 2048-2053
25. Weber M., Hausen M., Arnold R., et al. Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis. Heart 92 11 (Nov 2006) 1639-1644
26. Nessmith M.G., Fukuta H., Brucks S., and Little W.C. Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery. Am J Cardiol. 96 10 (Nov 15 2005) 1445-1448
27. Williams S.G., Barker D., Goldspink D.F., and Tan L.B. A reappraisal of concepts in heart failure: Central role of cardiac power reserve. Arch Med Sci 1 (2005) 65-74
28. Cotter G., Williams S.G., Vered Z., and Tan L.B. Role of cardiac power in heart failure. Curr Opin Cardiol 18 3 (May 2003) 215-222